National Cancer Genetics MDT
Information and tickets for the joint CanGene-CanVar and UKCGG National Cancer Genetics MDT are available for interested parties
Our most recent National MDT on September 16th, chaired by Dr Fiona Lalloo and Prof Marc Tischkowitz, was a fascinating session, including unsolved cases, and rare and unusual presentations of cancer predisposition syndromes.
One point of discussion at the meeting was management of carriers of the variant BRCA1 c.5096G>A p.Arg1699Gln (R1699Q), which is known to be associated with reduced disease risks compared to other pathogenic/likely pathogenic variants in this gene.
The consensus from this national meeting was that management of such carriers should be based on those guidelines published by the ENIGMA consortium, available to download here below.
Further information is available here.
Summaries of previous meetings, and recordings of sessions not involving sensitive patient information are available here.
The next meeting will be in November - details to follow in due course!
